Afoxolaner in Dogs

Afoxolaner is a prescription flea-and-tick medication for dogs. In the United States, pet parents most often know it by the brand name NexGard. It is an oral chewable in the isoxazoline drug class and is FDA-approved for dogs and puppies 8 weeks of age and older that weigh at least 4 pounds. The labeled use is monthly treatment and prevention of fleas plus treatment and control of several common tick species.

Because it is given by mouth, afoxolaner can be a practical option for dogs that swim often, get frequent baths, or dislike topical products. After your dog swallows the chew, the medication circulates in the body. Fleas and ticks are exposed when they bite. That means parasites usually need to attach and feed before they die, so pet parents may still see ticks on the dog for a period of time even when the product is working as intended.

Your vet may also use afoxolaner extra-label for certain mite problems, including demodectic mange, sarcoptic mange, or ear mites, depending on your dog’s history and exam findings. Extra-label use is common in veterinary medicine, but it should always be guided by your vet because the right plan depends on the parasite involved, your dog’s age, neurologic history, and any other medications being used.

Afoxolaner is not a one-size-fits-all choice. Some dogs do well on it for years. Others may need a different parasite prevention plan because of side effects, seizure history, lifestyle, or the need for broader parasite coverage such as heartworm prevention. That is why the best option is the one that fits your dog and your household, not the one with the longest feature list.

Afoxolaner belongs to the isoxazoline family. These drugs target ligand-gated chloride channels in insects and acarines, especially channels associated with gamma-aminobutyric acid, or GABA. Blocking those channels causes overexcitation of the parasite nervous system, which leads to paralysis and death. Mammals have different receptor sensitivity, which is why the drug can be used in dogs at labeled doses, though safety cautions still matter.

In practical terms, the chew does not create a surface coating on the skin. Instead, it is absorbed after your dog eats it and becomes available systemically. When fleas or ticks take a blood meal, they ingest the medication and die. The FDA prescribing information reports that NexGard began killing fleas within 4 hours in a laboratory study and showed greater than 99% effectiveness at 8 hours, with 100% effectiveness against adult fleas by 24 hours in a separate study.

The labeled duration is one month per dose. For flea control, year-round monthly use is often recommended in many parts of the United States because indoor heating, wildlife exposure, and regional climate can support flea survival even in cooler months. For tick control, consistent monthly dosing matters because missed doses can leave gaps in protection.

Afoxolaner is also part of combination products in some markets and in the U.S. brand NexGard PLUS, where it is paired with moxidectin and pyrantel to broaden parasite coverage. That does not make the combination automatically better for every dog. It means your vet can choose between a narrower flea-and-tick plan or a broader monthly prevention plan based on your dog’s needs.

The most commonly reported side effects with afoxolaner are digestive or general wellness changes rather than severe reactions. In the U.S. field study in the prescribing information, the most frequent adverse reaction was vomiting. Other reported reactions included dry or flaky skin, diarrhea, lethargy, and decreased appetite. Many mild stomach-related effects are short-lived, but your vet should still know if they happen, especially after the first dose.

The most important safety caution is neurologic risk. Afoxolaner is an isoxazoline, and this class has been associated with tremors, ataxia, and seizures. The FDA label states that seizures have been reported even in dogs without a prior seizure history, though dogs with a history of seizures or neurologic disorders should be treated with extra caution. This does not mean every dog is likely to have a neurologic event. It means the risk needs to be part of the decision.

Post-approval reports listed vomiting, itching, lethargy, diarrhea, decreased appetite, seizure, hyperactivity or restlessness, panting, redness of the skin, ataxia, dermatitis, allergic-type reactions, and tremors. Post-approval reporting cannot prove that the drug caused every event, but it helps vets and pet parents understand the range of problems that have been observed after real-world use.

See your vet immediately if your dog has a seizure, tremors, collapse, severe vomiting, facial swelling, trouble breathing, marked weakness, or behavior changes after a dose. Also contact your vet promptly if your dog is pregnant, nursing, intended for breeding, or has a known neurologic disorder, because the labeled safe use in breeding, pregnant, or lactating dogs has not been established.

Afoxolaner is dosed by body weight and should be given exactly as your vet prescribes. The FDA-approved NexGard chewables are formulated to provide a minimum dosage of 1.14 mg per pound, which is 2.5 mg/kg, and come in weight-based sizes. Dogs must be at least 8 weeks old and weigh 4 pounds or more. The chew is given once every 30 days.

Do not split, combine, or substitute chew sizes unless your vet specifically instructs you to do so. Weight-based parasite preventives are designed so each chew matches a dosing band. Using the wrong size can underdose or overdose your dog. If your dog is between package sizes, has recently gained or lost weight, or is still growing, ask your vet to confirm the correct strength before the next refill.

If a dose is missed, the prescribing information says to give the dose and resume a monthly schedule. Even so, it is smart to call your vet if the dose is late, especially if your dog has active fleas, heavy tick exposure, or is on a broader prevention plan that includes heartworm medication through a combination product. Timing matters more when there are multiple parasite risks in play.

Most dogs take the chew readily, but it should be given in a way that encourages chewing rather than swallowing whole. Store it securely and out of reach of pets and children. If your dog vomits soon after dosing, refuses the chew, or you are not sure the full dose was swallowed, contact your vet before repeating a dose.

No major routine drug interactions are prominently listed for afoxolaner on the standard product label, but that does not mean interaction screening is unnecessary. Your vet still needs a full medication list, including prescription drugs, over-the-counter products, supplements, and other parasite preventives. This is especially important if your dog takes medications that can affect the nervous system or has a history of seizures.

The biggest practical concern is overlap with other parasite products. Some dogs are on separate flea, tick, heartworm, and intestinal parasite medications. Others use a combination product such as NexGard PLUS. Doubling up by accident can happen when pet parents switch products, use leftover medication, or buy preventives from more than one source. Your vet can help make sure there is no unnecessary duplication.

If your dog needs treatment for mites, skin disease, allergies, or infection at the same time, your vet may still choose afoxolaner as part of the plan. That decision depends on the diagnosis, the severity of symptoms, and your dog’s overall risk profile. Dogs with neurologic disease, prior adverse reactions to isoxazolines, or uncertain medication histories may need a different route.

Before starting afoxolaner, tell your vet about any seizure history, tremors, balance problems, liver disease, pregnancy status, breeding plans, or prior reactions to flea and tick products. Those details often matter more than a formal drug-drug interaction list when your vet is choosing the safest prevention strategy.